# Innate Pharma SA: Form 6-K, filed Sep 12, 2024

- Company: [Innate Pharma SA](/companies/ipha.md) (CIK 1598599)
- Form: 6-K
- Filed: 2024-09-12
- Accepted by EDGAR: Sep 12, 2024, 06:07 ET
- Period: 2024-06-30
- Accession: 0001628280-24-040187
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1598599/000162828024040187/inpha-20240630.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1598599/000162828024040187/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1598599/000162828024040187/inpha-20240630.htm

Filed Sep 12, 2024.
Source: SEC EDGAR, the filing index for accession 0001628280-24-040187. Last ingested by Listed: Nov 5, 2026, 11:30 ET. No prices; not investment advice.